Clinical trial NCT05301231 - References

Non-Alcoholic Fatty Liver Disease — Omics-based Predictors of NAFLD/Potential NASH

Citation(s)

•   Ahmed MH, Noor SK, Bushara SO, Husain NE, Elmadhoun WM, Ginawi IA, Osman MM, Mahmoud AO, Almobarak AO
  Non-Alcoholic Fatty Liver Disease in Africa and Middle East: An Attempt to Predict the Present and Future Implications on the Healthcare System. Gastroenterology Res. 2017 Oct;10(5):271-279. doi: 10.14740/gr913w. Epub 2017 Oct 26. Review.
•   Beattie M, Dhawan A, Puntis JWL, et al
  , Non alcoholic fatty liver disease, chapter 61;520-528 Oxford Specialist Handbook of Paediatric Gastroenterology, Hepatology, and nutrition. Oxford university press, 3rd edition,2018
•   Castera L, Friedrich-Rust M, Loomba R
  Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019 Apr;156(5):1264-1281.e4. doi: 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18. Review.
•   Cheah MC, McCullough AJ, Goh GB
  Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease. J Clin Transl Hepatol. 2017 Sep 28;5(3):261-271. doi: 10.14218/JCTH.2017.00009. Epub 2017 Jun 24. Review.
•   Chow, S
  C.; Shao, J.; Wang, H. 2003. Sample Size Calculations in Clinical Research. Marcel Dekker. New York.
•   Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials, Board on Health Care Services, Board on Health Sciences Policy, Institute of Medicine; Micheel CM, Nass SJ, Omenn GS, editors
  Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington (DC): National Academies Press (US); 2012 Mar 23.
•   de Haan N, Falck D, Wuhrer M
  Monitoring of immunoglobulin N- and O-glycosylation in health and disease. Glycobiology. 2020 Mar 20;30(4):226-240. doi: 10.1093/glycob/cwz048. Review.
•   Gan L, Chitturi S, Farrell GC
  Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. Curr Gerontol Geriatr Res. 2011;2011:831536. doi: 10.1155/2011/831536. Epub 2011 Sep 12.
•   Giraudi PJ, Stephenson AM, Tiribelli C, Rosso N
  Novel high-throughput applications for NAFLD diagnostics and biomarker discovery. Hepatoma Res 2021; 7:2
•   Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L
  Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361. Review.
•   Matsuda K
  PCR-Based Detection Methods for Single-Nucleotide Polymorphism or Mutation: Real-Time PCR and Its Substantial Contribution Toward Technological Refinement. Adv Clin Chem. 2017;80:45-72. doi: 10.1016/bs.acc.2016.11.002. Epub 2017 Jan 4. Review.
•   Neuman MG, Cohen LB, Nanau RM
  Biomarkers in nonalcoholic fatty liver disease. Can J Gastroenterol Hepatol. 2014 Dec;28(11):607-18. Review.
•   Newby PK, Hu FB, Rimm EB, Smith-Warner SA, Feskanich D, Sampson L, Willett WC
  Reproducibility and validity of the Diet Quality Index Revised as assessed by use of a food-frequency questionnaire. Am J Clin Nutr. 2003 Nov;78(5):941-9.
•   Papari E, Noruzinia M, Kashani L, Foster WG
  Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction. Fertil Steril. 2020 Jun;113(6):1232-1241. doi: 10.1016/j.fertnstert.2020.01.026.
•   Patel K, Sebastiani G
  Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020 Jan 20;2(2):100067. doi: 10.1016/j.jhepr.2020.100067. eCollection 2020 Apr. Review.
•   Perakakis N, Stefanakis K, Mantzoros CS
  The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease. Metabolism. 2020 Oct;111S:154320. doi: 10.1016/j.metabol.2020.154320. Epub 2020 Jul 23. Review.
•   Rosenbaum J, Usyk M, Chen Z, Zolnik CP, Jones HE, Waldron L, Dowd JB, Thorpe LE, Burk RD
  Evaluation of Oral Cavity DNA Extraction Methods on Bacterial and Fungal Microbiota. Sci Rep. 2019 Feb 6;9(1):1531. doi: 10.1038/s41598-018-38049-6.
•   Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, Durmaz O, Lacaille F, McLin V, Nobili V
  Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012 May;54(5):700-13. doi: 10.1097/MPG.0b013e318252a13f.
•   Xin S, Zhan Q, Chen X, Xu J, Yu Y
  Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis. BMC Gastroenterol. 2020 Jun 12;20(1):186. doi: 10.1186/s12876-020-01334-8.
•   Younossi ZM, Reyes MJ, Mishra A, Mehta R, Henry L
  Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Aliment Pharmacol Ther. 2014 Jan;39(1):3-14. doi: 10.1111/apt.12543. Epub 2013 Nov 10. Review.

Omics-based Predictors of NAFLD/Potential NASH: A New Era Towards Valid and Reliable Non-invasive Diagnosis and Personalized Therapy

Details for clinical trial NCT05301231